Use of Antipsychotic Drugs in Patients with Alzheimer's Disease Treated with Rivastigmine versus Donepezil: A Retrospective, Parallel-Cohort, Hypothesis-Generating Study

Author： Scharre Douglas W.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.27, Iss.11, 2010-11, pp. : 903-913

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk of Antipsychotic Drug Use in Patients with Alzheimer’s Disease Treated with Rivastigmine

By Suh D-C.  

Drugs & Aging, Vol. 21, Iss. 6, 2004-01 ,pp. : 395-403

Adis International

Access to resources Recommend Favorite

Drug Persistency of Two Cholinesterase Inhibitors: Rivastigmine versus Donepezil in Elderly Patients with Alzheimer’s Disease

By Suh Dong-Churl  

Drugs & Aging, Vol. 22, Iss. 8, 2005-01 ,pp. : 695-707

Adis International

Access to resources Recommend Favorite

Causes of Syncope in Patients with Alzheimer’s Disease Treated with Donepezil

By Bordier Philippe   Lanusse Stephane   Garrigue Stephane   Reynard Charlotte   Robert Frederic   Gencel Laurent   Lafitte Alexia  

Drugs & Aging, Vol. 22, Iss. 8, 2005-01 ,pp. : 687-694

Adis International

Access to resources Recommend Favorite

Donepezil vs rivastigmine in Alzheimer's disease - same benefits, different downsides

By  

Inpharma, Vol. 1, Iss. 1300, 2001-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Donepezil is better tolerated than rivastigmine in mild-to-moderate Alzheimer's disease

By  

Inpharma, Vol. 1, Iss. 1258, 2000-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite